Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024;31(4):507-511.
doi: 10.5603/cj.98927.

Are we at dawn of the drug-coated balloons era? Current evidence, future directions, and tasks of the newly established working group of the Association of Cardiovascular Interventions

Sylwia Iwańczyk  1   2 , Kamil Bujak  3 , Rafał Wolny  4 , Adam Janas  5   6 , Miłosz Dziarmaga  7 , Maksymilian P Opolski  4 , Rafał Januszek  8 , Adrian Włodarczak  9   10 , Piotr Desperak  11 , Piotr Niezgoda  12 , Michał Kryjak, Mariusz Tomaniak  13 , Zenon Huczek  13 , Michał Hawranek  3 , Bernardo Cortese  2   14 , Wojciech Wańha  15   16
Affiliations
Editorial

Are we at dawn of the drug-coated balloons era? Current evidence, future directions, and tasks of the newly established working group of the Association of Cardiovascular Interventions

Sylwia Iwańczyk et al. Cardiol J. 2024.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
The current and expanding applications of drug-coated balloons
See this image and copyright information in PMC

References

    1. Sabaté M, Brugaletta S, Cequier A, et al. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial. JACC Cardiovasc Interv. 2014;7(1):64–71. doi: 10.1016/j.jcin.2013.09.006. - DOI - PubMed
    1. Cortese B, Kalkat H, Bathia G, et al. The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data. Catheter Cardiovasc Interv. 2023;102(6):1069–1077. doi: 10.1002/ccd.30891. - DOI - PubMed
    1. Sabaté M, Alfonso F, Cequier A, et al. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial. Circulation. 2019;140(23):1904–1916. doi: 10.1161/CIRCULATIONAHA.119.043467. - DOI - PubMed
    1. Wańha W, Bil J, Januszek R, et al. Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry) Circ Cardiovasc Interv. 2021;14(9):e010868. doi: 10.1161/CIRCINTERVENTIONS.121.010868. - DOI - PubMed
    1. Giacoppo D, Alfonso F, Xu Bo, et al. Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study) Eur Heart J. 2020;41(38):3715–3728. doi: 10.1093/eurheartj/ehz594. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources